IMGN - Immunogen Inc. (IMGN) CEO Mark Enyedy on Q1 2019 Results - Earnings Call Transcript
Immunogen Inc. (IMGN)
Q1 2019 Earnings Conference Call
May 3, 2019 08:00 ET
Company Participants
Sarah Kiely - Director, Investor Relations and Corporate Communications
Mark Enyedy - President and Chief Executive Officer
Anna Berkenblit - Chief Medical Officer
Rich Gregory - Chief Scientific Officer
Dave Foster - Chief Accounting Officer
Conference Call Participants
John Newman - Canaccord
Andy Hsieh - William Blair
Kennen MacKay - RBC Capital Markets
Michael Schmidt - Guggenheim
Biren Amin - Jefferies
David Ruch - SVB Leerink
Boris Peaker - Cowen
Jessica Fye - JPMorgan
Debjit Chattopadhyay - H.C. Wainwright
Presentation